Professor, CHRISTIAN ALBRECHTS UNIVERSITAT ZU KIEL
Member of the Healthcare Council
Stefan Schreiber, MD, is Professor of Medicine and Gastroenterology at the Christian-Albrechts-University in Germany. Dr. Schreiber is responsible for designing, organizing, and conducting phase IB-III clinical trials of novel drugs for inflammatory bowel disease and the functional disorders of the gastrointestinal tract. His clinical research interests are in tuberculosis and gastrointestinal cancer. He also leads a research institute that focuses on the genetics of complex disease and inflammatory pathophysiology. Dr. Schreiber is the scientific speaker of the German National Genome Research Network and a consultant for various pharmaceutical companies' clinical development programs for gastrointestinal and pulmonary diseases. (This is me - Update Profile)
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
Stefan Schreiber has not published any GLG News Analyses.
| Study Group Name | No. Members |
|---|---|
| Oncologists (EU) | 788 |
| Gastroenterologists who Treat GERD | 419 |
| Oncologists (Germany, France, Italy) | 352 |
| IBD Gastroenterologists | 301 |
| Council Members who Treat Colon/Colorectal Cancer | 275 |
Stefan Schreiber has not participated in any GLG Live Meetings.